Honor Health Research and Innovation Institute

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3)	Arrhythmias, Cardiac, Cardiac Conduction System Disease, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, congenital heart disease, heart disorder	Recruiting	Phase 2 / Phase 3	2026-09-21		NCT07277582
AOH1996 for the Treatment of Refractory Solid Tumors	Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, bronchial neoplasm, bronchogenic carcinoma, connective tissue neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, leiomyosarcoma, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, myomatous neoplasm, neoplasm, non-small cell lung carcinoma, osteosarcoma, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, respiratory system disorder, respiratory tract neoplasm, sarcoma, synovial sarcoma	Recruiting	Phase 1	2026-07-28		NCT05227326

Clinical trials